Based in Hyderabad, India, Bharat Biotech is expanding its vaccine portfolio with a focus on antimicrobial resistance (AMR), a growing global health challenge. The company, known internationally for developing Covaxin during the Covid-19 pandemic, is now working on vaccines designed to prevent hospital-acquired infections, particularly in patients undergoing surgeries. According...